紫杉醇治疗期间化疗引起的局限性中毒性红斑。 - Suppr | 超能文献

Localized toxic erythema of chemotherapy during treatment with paclitaxel.

作者信息

Spicknall Kerith E, Mutasim Diya F

机构信息

Department of Dermatology, University of Cincinnati, Cincinnati, OH, USA E-mail:

出版信息

Int J Dermatol. 2014 Jan;53(1):e3-5. doi: 10.1111/j.1365-4632.2012.05573.x. Epub 2013 Mar 3.

DOI:10.1111/j.1365-4632.2012.05573.x

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Localized toxic erythema of chemotherapy during treatment with paclitaxel.紫杉醇治疗期间化疗引起的局限性中毒性红斑。

Int J Dermatol. 2014 Jan;53(1):e3-5. doi: 10.1111/j.1365-4632.2012.05573.x. Epub 2013 Mar 3.

2

Scleroderma induced by paclitaxel.紫杉醇诱导的硬皮病。

Acta Oncol. 2010 Aug;49(6):866-8. doi: 10.3109/02841861003702510.

3

[Myocardial infarction after paclitaxel use].[使用紫杉醇后发生心肌梗死]

Therapie. 2003 Sep-Oct;58(5):467-9. doi: 10.2515/therapie:2003077.

4

Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study.紫杉醇新辅助腹腔化疗联合细胞减灭术治疗卵巢癌腹膜转移癌的前瞻性研究。

Cancer Chemother Pharmacol. 2011 Jul;68(1):267-74. doi: 10.1007/s00280-011-1646-4. Epub 2011 Apr 17.

5

Carboplatin plus paclitaxel in the treatment of gynecologic malignancies: the Cleveland Clinic experience.卡铂联合紫杉醇治疗妇科恶性肿瘤：克利夫兰诊所的经验。

Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-26-S15-29.

6

Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survival.干扰素γ-1b联合标准卡铂/紫杉醇与单纯卡铂/紫杉醇一线治疗晚期卵巢癌和原发性腹膜癌的随机3期试验：无进展生存期前瞻性设计分析结果

Gynecol Oncol. 2008 May;109(2):174-81. doi: 10.1016/j.ygyno.2008.01.005. Epub 2008 Mar 7.

7

Intraperitoneal chemotherapy for ovarian cancer.卵巢癌的腹腔内化疗

Oncol Nurs Forum. 2012 Jul;39(4):346-9. doi: 10.1188/12.ONF.346-349.

8

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study.每周一次紫杉醇（80mg/m²）用于铂类和紫杉醇耐药的卵巢癌及原发性腹膜癌的II期试验：一项妇科肿瘤学组研究

Gynecol Oncol. 2006 Jun;101(3):436-40. doi: 10.1016/j.ygyno.2005.10.036. Epub 2005 Dec 2.

9

Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.卡铂/紫杉醇与顺铂/紫杉醇作为晚期卵巢癌一线化疗方案的比较：妇科肿瘤学 Arbeitsgemeinschaft 卵巢癌研究组一项随机 III 期试验的中期分析

Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-44-S15-52.

10

[Taxol in the treatment of ovarian neoplasm].[紫杉醇治疗卵巢肿瘤]

Zhonghua Fu Chan Ke Za Zhi. 1999 Jul;34(7):439-41.

引用本文的文献

1

Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model.紫杉醇诱导的表皮改变：原代角质形成细胞和 3D 表皮模型的体外临床前评估。

Int J Mol Sci. 2022 Jan 20;23(3):1142. doi: 10.3390/ijms23031142.

2

Dermatological adverse events with taxane chemotherapy.紫杉烷类化疗的皮肤不良事件。

Eur J Dermatol. 2016 Oct 1;26(5):427-443. doi: 10.1684/ejd.2016.2833.